Eli Lilly and Company (LLY)
Pre-Market:
| Previous Close | 807.43 |
| Open | 809.00 |
| Bid | 800.11 x 1200 |
| Ask | 805.00 x 800 |
| Day's Range | 788.25 - 809.00 |
| 52 Week Range | 424.01 - 820.61 |
| Volume | |
| Avg. Volume | 2,723,022 |
| Market Cap | 767.794B |
| Beta (5Y Monthly) | 0.37 |
| PE Ratio (TTM) | 118.98 |
| EPS (TTM) | 6.79 |
| Earnings Date | Aug 08, 2024 |
| Forward Dividend & Yield | 5.20 (0.64%) |
| Ex-Dividend Date | May 15, 2024 |
| 1y Target Est | 859.23 |
PR NewswireLilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
During the World Health Assembly today, Eli Lilly and Company (NYSE: LLY) announced it will donate $6.5 million to the United States Fund for UNICEF to expand UNICEF's work to improve the health outcomes of millions of children and youth at risk of noncommunicable diseases (NCDs) living in resource-limited settings in India. This will bring the company's total commitment since 2022 to more than $20 million.
- PR Newswire
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024. Patrik Jonsson, executive vice president, president of Lilly Diabetes and Obesity, and president of Lilly USA, will participate in a fireside chat at 4 p.m. Eastern time.
ZacksEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
